Development of a Novel Tool for the Retrieval and Analysis of Hormone Receptor Expression Characteristics in Metastatic Breast Cancer via Data Mining on Pathology Reports

被引:1
作者
Chang, Kai-Po [1 ,2 ]
Wang, John [2 ]
Chang, Chi-Chang [3 ,4 ]
Chu, Yen-Wei [5 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Natl Chung Hsing Univ, PhD Program Med Biotechnol, Taichung 402, Taiwan
[2] China Med Univ Hosp, Dept Pathol, Taichung 404, Taiwan
[3] Chung Shan Med Univ, Sch Med Informat, Taichung 402, Taiwan
[4] Chung Shan Med Univ Hosp, IT Off, Taichung 402, Taiwan
[5] Natl Chung Hsing Univ, Inst Genom & Bioinformat, 145 Xingda Rd, Taichung 402, Taiwan
[6] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan
[7] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan
[8] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung 402, Taiwan
[9] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung 402, Taiwan
[10] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan
关键词
PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; AMERICAN SOCIETY; IMMUNOHISTOCHEMISTRY; TEXT; RECOMMENDATIONS; POPULATION; PATHWAY;
D O I
10.1155/2020/2654815
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Information about the expression status of hormone receptors such as estrogen receptor (ER), progesterone receptor (PR), and Her-2 is crucial in the management and prognosis of breast cancer. Therefore, the retrieval and analysis of hormone receptor expression characteristics in metastatic breast cancer may be valuable in breast cancer study. Herein, we report a text mining tool based on word/phrase matching that retrieves hormone receptor expression data of regional or distant metastatic breast cancer from pathology reports. It was tested on pathology reports at the China Medical University Hospital from 2013 to 2018. The tool showed specificities of 91.6% and 63.3% for the detection of regional lymph node metastasis and distant metastasis, respectively. Sensitivity in immunohistochemical study result extraction in these cases was 98.6% for distant metastasis and 78.3% for regional lymph node metastasis. Statistical analysis on these retrieved data showed significant difference s in PR and Her-2 expressions between regional and metastatic breast cancer, which is compatible with previous studies. In conclusion, our study shows that metastatic breast cancer hormone receptor expression characteristics can be retrieved by text mining. The algorithm designed in this study may be useful in future studies about text mining in pathology reports.
引用
收藏
页数:7
相关论文
共 39 条
  • [11] Hormone receptor status, erbB2 expression and cancer stem cell characteristics of circulating tumor cells in breast cancer patients
    Rack, Brigitte
    Bock, Carolin
    Andergassen, Ulrich
    Doisneau-Sixou, Sophie
    HISTOLOGY AND HISTOPATHOLOGY, 2012, 27 (07) : 855 - 864
  • [12] Estrogen Receptor Expression and Docetaxel Efficacy in Patients with Metastatic Breast Cancer: A Pooled Analysis of Four Randomized Trials
    Andre, Fabrice
    Broglio, Kristine
    Pusztai, Lajos
    Berrada, Narjiss
    Mackey, John R.
    Nabholtz, Jean Marc
    Chan, Stephen
    Hortobagyi, Gabriel N.
    ONCOLOGIST, 2010, 15 (05) : 476 - 483
  • [13] Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease
    Rossi, Sabrina
    Basso, Michele
    Strippoli, Antonia
    Dadduzio, Vincenzo
    Cerchiaro, Eleonora
    Le, Rosalba Bari
    D'Argento, Ettore
    Cassano, Alessandra
    Schinzari, Giovanni
    Barone, Carlo
    CLINICAL BREAST CANCER, 2015, 15 (05) : 307 - 312
  • [14] The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial
    Bravaccini, Sara
    Bronte, Giuseppe
    Scarpi, Emanuela
    Ravaioli, Sara
    Maltoni, Roberta
    Mangia, Anita
    Tumedei, Maria Maddalena
    Puccetti, Maurizio
    Serra, Patrizia
    Gianni, Lorenzo
    Amaducci, Laura
    Biglia, Nicoletta
    Bounous, Valentina
    Paradiso, Angelo Virgilio
    Silvestrini, Rosetta
    Amadori, Dino
    Rocca, Andrea
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [15] Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs
    Cobleigh, Melody
    Yardley, Denise A.
    Brufsky, Adam M.
    Rugo, Hope S.
    Swain, Sandra M.
    Kaufman, Peter A.
    Tripathy, Debu
    Hurvitz, Sara A.
    O'Shaughnessy, Joyce
    Mason, Ginny
    Antao, Vincent
    Li, Haocheng
    Chu, Laura
    Jahanzeb, Mohammad
    CLINICAL CANCER RESEARCH, 2020, 26 (05) : 1105 - 1113
  • [16] Hormone Receptor Expression Is Associated With a Unique Pattern of Metastatic Spread and Increased Survival Among HER2-Overexpressing Breast Cancer Patients
    Paluch-Shimon, Shani
    Ben-Baruch, Noa
    Wolf, Ido
    Zach, Lior
    Kopolovic, Juri
    Kruglikova, Anna
    Modiano, Tami
    Yosepovich, Ady
    Catane, Raphael
    Kaufman, Bella
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (05): : 504 - 508
  • [17] Quantitative hormone receptor (HR) expression and gene expression analysis in HR plus inflammatory breast cancer (IBC) vs non-IBC
    Iwase, Toshiaki
    Harano, Kenichi
    Masuda, Hiroko
    Kida, Kumiko
    Hess, Kenneth R.
    Wang, Ying
    Dirix, Luc
    Van Laere, Steven J.
    Lucci, Anthony
    Krishnamurthy, Savitri
    Woodward, Wendy A.
    Layman, Rachel M.
    Bertucci, Francois
    Ueno, Naoto T.
    BMC CANCER, 2020, 20 (01)
  • [18] Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
    Toshiaki Iwase
    Kenichi Harano
    Hiroko Masuda
    Kumiko Kida
    Kenneth R. Hess
    Ying Wang
    Luc Dirix
    Steven J. Van Laere
    Anthony Lucci
    Savitri Krishnamurthy
    Wendy A. Woodward
    Rachel M. Layman
    François Bertucci
    Naoto T. Ueno
    BMC Cancer, 20
  • [19] Breast cancer aromatase expression evaluated by the novel antibody 677: Correlations to intra-tumor estrogen levels and hormone receptor status
    Geisler, Jurgen
    Suzuki, Takashi
    Helle, Hildegunn
    Miki, Yasuhiro
    Nagasaki, Shuji
    Duong, Nhat K.
    Ekse, Dagfinn
    Aas, Turid
    Evans, Dean B.
    Lonning, Per E.
    Sasano, Hironobu
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 118 (4-5) : 237 - 241
  • [20] Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor-Positive Breast Cancer
    Ramkumar, Charusheila
    Buturovic, Ljubomir
    Malpani, Sukriti
    Attuluri, Arun Kumar
    Basavaraj, Chetana
    Prakash, Chandra
    Madhav, Lekshmi
    Doval, Dinesh Chandra
    Mehta, Anurag
    Bakre, Manjiri M.
    BIOMARKER INSIGHTS, 2018, 13